Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions.
Flexion is based in Burlington, Massachusetts.
View our terms of use: https://flexiontherapeutics.com/terms-of-use/
|
|
|
11-50 employees
View all Flexion Therapeutics employees
|
|
Biotechnology
|
|
$10M–$50M
|
|
(781) 357-4000
|
|
10 Mall Road, Suite 301, Burlington, Massachusetts 01803, US
|
|
2007
|
|
Osteoarthritis And Pain Management
|
The decision makers in Flexion Therapeutics are Carolyn Scimemi, Ben Minihane, Bill Tam, etc. Click to Find Flexion Therapeutics decision makers emails.
Flexion Therapeutics headquarters is located at 10 Mall Road, Suite 301, Burlington, Massachusetts 01803, US.
Flexion Therapeutics generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Flexion Therapeutics by calling (781) 357-4000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.